At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AEMD Aethlon Medical
Pre-Market Trading 06-28 06:30:31 EDT
0.5786
-0.0064
-1.09%
盘前0.5499
-0.0287-4.96%
06:26 EDT
High0.6085Low0.5513Vol1.81M
Open0.5969D1 Closing0.5850Amplitude9.78%
Mkt Cap5.34MTradable Cap5.22MTotal Shares9.23M
T/O1.05MT/O Rate20.03%Tradable Shares9.02M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary
Reuters  ·  05:36
Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary
BRIEF-Aethlon Medical Announces Financial Results For The Fiscal Year Ended March 31, 2024 And Provides Corporate Update
Reuters  ·  04:30
BRIEF-Aethlon Medical Announces Financial Results For The Fiscal Year Ended March 31, 2024 And Provides Corporate Update
BRIEF-Aethlon Medical- Co Received Multiple Inquiries Regarding Current, Multi-State Outbreak Of H5n1 Avian Influenza (H5n1 Hpai) Virus In Dairy Cattle
Reuters  ·  04:29
BRIEF-Aethlon Medical- Co Received Multiple Inquiries Regarding Current, Multi-State Outbreak Of H5n1 Avian Influenza (H5n1 Hpai) Virus In Dairy Cattle
Aethlon Medical GAAP EPS of -$4.86 beats by $0.33
seekingalpha  ·  04:18
Aethlon Medical GAAP EPS of -$4.86 beats by $0.33
Aethlon Medical FY 2024 GAAP EPS $(4.86) Beats $(5.22) Estimate
Benzinga  ·  04:17
Aethlon Medical FY 2024 GAAP EPS $(4.86) Beats $(5.22) Estimate
Press Release: Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
Dow Jones  ·  04:15
Press Release: Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  06-27 18:00
Calendar of U.S. Earnings Expected in the Week Ahead
Aethlon Medical FY 2024 Earnings Preview
seekingalpha  ·  06-27 05:35
Aethlon Medical FY 2024 Earnings Preview
Aethlon Medical Inc expected to post a loss of $1.23 a share - Earnings Preview
Reuters  ·  06-25
Aethlon Medical Inc expected to post a loss of $1.23 a share - Earnings Preview
HC Wainwright Adjusts Aethlon Medical Price Target to $7 From $10, Maintains Buy Rating
MT Newswires Live  ·  06-24
HC Wainwright Adjusts Aethlon Medical Price Target to $7 From $10, Maintains Buy Rating
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
Dow Jones  ·  06-24
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
AEMD: Ethics Committee Approval for Safety, Feasibility, Dose-Finding Trial Important Step in Advancing the Hemopurifier
Zacks Small Cap Research  ·  06-24
AEMD: Ethics Committee Approval for Safety, Feasibility, Dose-Finding Trial Important Step in Advancing the Hemopurifier
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  06-24
Calendar of U.S. Earnings Expected in the Week Ahead
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
PR Newswire  ·  06-21
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
What's Next in Treatments for Cancer Patients with Solid Tumors?
Newsfile  ·  06-20
What's Next in Treatments for Cancer Patients with Solid Tumors?
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  06-20
Calendar of U.S. Earnings Expected in the Week Ahead
BRIEF-Aethlon Medical Receives Ethics Committee Approval For Hemopurifier® Cancer Trial
Reuters  ·  06-18
BRIEF-Aethlon Medical Receives Ethics Committee Approval For Hemopurifier® Cancer Trial
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial
PR Newswire  ·  06-18
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial
The Hunt for Virus Treatments Continues Post Covid-19
Newsfile  ·  06-07
The Hunt for Virus Treatments Continues Post Covid-19
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID
Newsfile  ·  06-03
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Introduction

Company Name.
Aethlon Medical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Issue price:
--